Skip to main content
Fig. 5 | Cancer Cell International

Fig. 5

From: Midazolam increases cisplatin-sensitivity in non-small cell lung cancer (NSCLC) via the miR-194-5p/HOOK3 axis

Fig. 5

Upregulation of HOOK3 rescued cell viability in midazolam and cisplatin co-treated CR-NSCLC cells. We performed A, B MTT assay and C, D trypan blue staining assay to respectively examine cell proliferation and viability in the CR-NSCLC cells. EG Cell apoptosis ratio in CR-NSCLC cells was examined by FCM assay. Individual experiment contained at least 3 repetitions, and *P < 0.05, **P < 0.01, and ***P < 0.001 was considered as statistical significance

Back to article page